NEXGEL, Inc.
NXGLW
NASDAQ Capital Market0.04
USD
-0.01
- -
CIK
0001468929
ISIN
US65344E1156
CUSIP
65344E115
Return %
Stock
S&P500
1Y
-85.47
26.53
3Y
-89.58
76.60
5Y
-94.87
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Adam R. Levy
- Full Time Employees
- 19
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 2150 Cabot Boulevard West Langhorne PA United States of America 19047
- IPO Date
- Dec 22, 2021
- CIK
- 0001468929
- Website
- nexgel.com
- Similar Companies
- Business
- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW) manufactures and sells high-water-content, electron beam cross-linked aqueous polymer hydrogels and gels for healthcare, consumer wellness, medical device, cosmetic, and transdermal drug delivery applications in the United States. The company offers branded over-the-counter (OTC) remedy solutions including wound care products such as SilverSeal and MEDAGEL; foot care items like Turfguard and Kenkoderm; beauty and cosmetic patches under brands including Silly George, LumaGel Beauty, and Cancoderm; conductive and non-conductive hydrogels for medical diagnostics and electrodes; blister, pain, and first-aid applications; temperature management solutions; and custom hydrogel formulations for contract manufacturing clients. Through its CG Converting & Packaging subsidiary, NEXGEL provides contract development, converting, packaging, and high-volume production services to medical device OEMs, cosmetic brands, and consumer product companies, leveraging its FDA-registered, ISO-certified, cGMP 16,500 square foot facility for R&D, formulation of over 200 combinations, and production without chemical cross-linkers or adhesives. Founded in 2009 and headquartered in Langhorne, Pennsylvania, the company formerly known as AquaMed Technologies, Inc. until its rebranding in November 2019, operates primarily in the medical instruments and supplies sector with 19 employees targeting healthcare professionals, B2B partners, and direct-to-consumer retail and e-commerce channels. In recent developments, NEXGEL reported second quarter 2025 revenue of $2.88 million, reflecting 100.3% year-over-year growth driven by consumer products and contract manufacturing, while maintaining full-year 2025 guidance of $13 million in revenue and positive EBITDA. The company expanded its strategic partnership with STADA AG in July 2025, securing $1 million in non-dilutive capital to fund North American product launches and marketing of hydrogel-based health solutions, alongside partnerships with Cintas for SilverSeal wound dressings and AbbVie. Additional 2025 milestones include acquisitions of the Silly George beauty brand and Cancoderm to broaden its personal care portfolio; a $1.05 million financing round and $950,000 registered direct offering for growth initiatives; appointment of Steve Ciardiello, CPA, Chief Accounting Officer of Shutterstock, to its board; and cancellation of a special stockholder meeting on share increases. NEXGEL continues to advance its medical device pipeline with products like NEXDrape incise surgical drape, NEXDerm adhesive tape for securing medical lines, and Premalas psoriasis patch, positioning it for scaled production and new market penetration.
NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration
NEXGEL, Inc. (NXGL) Q1 2026 Earnings Call Transcript
NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical
NEXGEL To Report First Quarter 2026 Financial Results on May 15th
NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors
NEXGEL, Inc. (NXGL) Q4 2025 Earnings Call Transcript
NEXGEL (NASDAQ:NXGLW) Stock Price Up 46.5% – What’s Next?
NEXGEL (NASDAQ:NXGLW) Shares Up 18.3% – Time to Buy?